| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 258 | 28.640 | 25.407 | 30.251 | 37.346 | 39.586 | 40.219 |
| Total Income - EUR | - | - | - | 258 | 31.485 | 27.823 | 30.251 | 37.346 | 39.586 | 40.219 |
| Total Expenses - EUR | - | - | - | 208 | 22.208 | 19.550 | 21.259 | 22.275 | 35.531 | 36.915 |
| Gross Profit/Loss - EUR | - | - | - | 49 | 9.277 | 8.273 | 8.991 | 15.071 | 4.055 | 3.303 |
| Net Profit/Loss - EUR | - | - | - | 47 | 8.991 | 8.081 | 8.793 | 14.705 | 3.719 | 2.556 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Elmar Biomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 12.544 | 12.554 | 10.918 | 9.310 | 8.711 | 7.270 | 5.797 |
| Current Assets | - | - | - | 1.172 | 4.181 | 7.115 | 17.400 | 9.303 | 12.774 | 17.036 |
| Inventories | - | - | - | 682 | 1.381 | 2.431 | 2.417 | 2.041 | 4.101 | 4.202 |
| Receivables | - | - | - | 0 | 0 | 17 | 0 | 0 | 0 | 1.005 |
| Cash | - | - | - | 490 | 2.800 | 4.668 | 14.983 | 7.262 | 8.674 | 11.828 |
| Shareholders Funds | - | - | - | 90 | 9.079 | 16.988 | 25.404 | 14.754 | 18.427 | 20.880 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 13.626 | 7.657 | 1.045 | 1.306 | 3.261 | 1.617 | 1.953 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Elmar Biomed S.r.l.